Abdelwahab, E. M. M.Pal, S.Kvell, K.Sarosi, V.Bai, P.Rue, R.Krymskaya, V.McPhail, D.Porter, A.Pongracz, J. E.2019-01-172019-01-172019Abdelwahab, E M M, Pal, S, Kvell, K, Sarosi, V, Bai, P, Rue, R, Krymskaya, V, McPhail, D, Porter, A & Pongracz, J E 2019, 'Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target', Oncogene, vol. 38, pp. 3093-3101. https://doi.org/10.1038/s41388-018-0625-11476-5594RIS: urn:4DD4F61B3ED263D6AB099AEA3231E6DDRIS: Abdelwahab2018Mendeley: 36e6dfde-b7b9-3d37-854b-7497f4cc948bhttp://hdl.handle.net/2164/11805Acknowledgements The authors are grateful to Prof. Dr. Laszlo Seress, Professor Emeritus, Central Electron Microscope Laboratory, University of Pecs, Pecs, Hungary for his invaluable assistance with electron microscopic studies using the Jeol 1200 TEM and Jeol 1400 TEM electron microscopes. Jeol TEM was funded by the GINOP-2.3.3-15-2016-0002 (New generation electron microscope: 3D ultrastructure). We would also like to thank Dr. Veronika Csongei, PhD, Senior Lecturer, Department of Pharmaceutical Biotechnology and Janos Szentagothai Research Centre, University of Pecs, Pecs, Hungary for assistance with statistical analysis. Funding JEP was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TÁMOP-4.2.4.A/2-11/1-2012-0001 “National Excellence Program”.92816832engSDG 3 - Good Health and Well-beingBIOGENESISCELLCHAINCYTOCHROME-CESTROGENFEATURESGENEPHOSPHORYLATIONTSC2QH301 BiologyGeneticsMolecular BiologyCancer ResearchSupplementary DataQH301Journal article10.1038/s41388-018-0625-1http://www.scopus.com/inward/record.url?scp=85058854414&partnerID=8YFLogxKhttp://www.mendeley.com/research/mitochondrial-dysfunction-key-determinant-rare-disease-lymphangioleiomyomatosis-provides-novel-thera38